| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,740 |
2,378 |
$278K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,762 |
1,297 |
$74K |
| 99215 |
Prolong outpt/office vis |
297 |
223 |
$21K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
94 |
87 |
$4K |
| 99401 |
|
132 |
120 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
43 |
43 |
$3K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
63 |
49 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
93 |
72 |
$1K |
| 69210 |
|
22 |
21 |
$988.69 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$923.56 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
54 |
52 |
$583.93 |
| 20552 |
|
12 |
12 |
$147.52 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
18 |
18 |
$95.97 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
17 |
17 |
$75.48 |